Related Experiment Video
Updated: Jul 16, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells
Young-Rae Lee1, Hong-Nu Yu, Eun-Mi Noh
1Department of Biochemistry, Chonbuk National University Medical School, Jeonju 561-180, Korea.
Abstract:
TNF-alpha plays a variety of biological functions such as apoptosis, inflammation and immunity. PTEN also has various cellular function including cell growth, proliferation, migration and differentiation. Thus, possible relationships between the two molecules are suggested. TNF-alpha has been known to downregulate PTEN via NF-kappaB pathway in the human colon cell line, HT-29. However, here we show the opposite finding that TNF-alpha upregulates PTEN via activation of NF-kappaB in human leukemic cells. TNF-alpha increased PTEN expression at HL-60 cells in a time- and dose-dependent manner, but the response was abolished by disruption of NF-kappaB with p65 antisense phosphorothioate oligonucleotide or pyrrolidine dithiocarbamate. We found that TNF-alpha activated the NF-kappaB pathways, evidenced by the translocation of p65 to the nucleus in TNF-alpha-treated cells. We conclude that TNF-alpha induces upregulation of PTEN expression through NF-kappaB activation in human leukemic cells.
Insights
Tumor Necrosis Factor-alpha (TNF-alpha) upregulates PTEN expression in human leukemic cells. This occurs through the activation of the NF-kappaB pathway, contrary to previous findings in colon cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Tumor Necrosis Factor-alpha (TNF-alpha) is a cytokine involved in apoptosis, inflammation, and immunity.
- Phosphatase and Tensin homolog (PTEN) is a tumor suppressor protein regulating cell growth, proliferation, migration, and differentiation.
- Previous studies indicated TNF-alpha downregulates PTEN via the NF-kappaB pathway in HT-29 colon cells.
Purpose of the Study:
- To investigate the relationship between TNF-alpha and PTEN expression in human leukemic cells.
- To elucidate the specific molecular pathway involved in TNF-alpha's effect on PTEN.
Main Methods:
- Treatment of HL-60 human leukemic cells with TNF-alpha.
- Assessment of PTEN expression levels in a time- and dose-dependent manner.
- Inhibition of the NF-kappaB pathway using p65 antisense phosphorothioate oligonucleotide and pyrrolidine dithiocarbamate.
- Analysis of NF-kappaB activation by examining the nuclear translocation of the p65 subunit.
Main Results:
- TNF-alpha significantly increased PTEN expression in HL-60 cells.
- The observed increase in PTEN was dose- and time-dependent.
- Inhibition of NF-kappaB activation abolished the TNF-alpha-induced upregulation of PTEN.
- TNF-alpha treatment led to the activation of NF-kappaB, confirmed by p65 nuclear translocation.
Conclusions:
- TNF-alpha induces the upregulation of PTEN expression in human leukemic cells.
- This upregulation is mediated by the activation of the NF-kappaB signaling pathway.
- The findings present an opposite effect of TNF-alpha on PTEN compared to previous observations in non-leukemic cells.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Canonical Wnt Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
